Background Synapse damage and loss are fundamental to the pathophysiology of
Alzheimer's disease (AD) and lead to reduced cognitive function. The goal of this review is to …

Currently established and employed biomarkers of Alzheimer's disease (AD) predominantly
mirror AD-associated molecular and structural brain changes. While they are necessary for …

Background Although numerous electroencephalogram (EEG) studies have described
differences in functional connectivity in Alzheimer's disease (AD) compared to healthy …

This study will concentrate on recent research on EEG signals for Alzheimer's diagnosis,
identifying and comparing key steps of EEG-based Alzheimer's disease (AD) detection, such …

Objectives To investigate using quantitative EEG the (1) differences between patients with
mild cognitive impairment with Lewy bodies (MCI-LB) and MCI with Alzheimer's disease …

Alzheimer's disease is a neurodegenerative disease in old age, early diagnosis will help to
delay the progression of the disease. Presently, the features of brain functional diseases can …

Previous studies showed that entrainment of light flicker at low gamma frequencies provided
neuroprotection in mouse models of Alzheimer's disease (AD) and stroke. The current study …

Background and objective With the acceleration of social rhythm and the increase of
pressure, there are various sleep problems among people. Sleep staging is an important …

Objective Early biomarkers for dementia with Lewy bodies (DLB) are lacking. To determine
whether EEG differentiates the prodromal phase of DLB from other causes of mild cognitive …

The Lewy Body Dementia Association (LBDA) held a virtual event, the LBDA Biofluid/Tissue
Biomarker Symposium, on January 25, 2021, to present advances in biomarkers for Lewy …